{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:44:00Z","timestamp":1789685040695,"version":"4.0.1"},"reference-count":35,"publisher":"American Society for Microbiology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Vaccine Immunol."],"published-print":{"date-parts":[[2015,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The Zagreb regimen, an abbreviated intramuscular schedule for rabies vaccination, was developed by I. Vodopija and colleagues of the Zagreb Institute of Public Health in Croatia in the 1980s. It was recommended by WHO as one of the intramuscular (IM) schedules for rabies vaccination in 2010. We reviewed the literature on the immunogenicity, safety, economic burden, and compliance of the Zagreb 2-1-1 regimen. Compared to Essen, another IM schedule recommended by WHO, Zagreb has higher compliance, lower medical cost, and better immunogenicity at an early stage.<\/jats:p>","DOI":"10.1128\/cvi.00531-14","type":"journal-article","created":{"date-parts":[[2014,11,13]],"date-time":"2014-11-13T05:06:43Z","timestamp":1415855203000},"page":"1-5","source":"Crossref","is-referenced-by-count":18,"title":["Zagreb Regimen, an Abbreviated Intramuscular Schedule for Rabies Vaccination"],"prefix":"10.1128","volume":"22","author":[{"given":"Jiangping","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","published-online":{"date-parts":[[2014,11,12]]},"reference":[{"key":"key20180919073752_B1","unstructured":"World Health Organization. 2013. Rabies. Accessed 18 November 2013. http:\/\/www.who.int\/mediacentre\/factsheets\/fs099\/en\/."},{"key":"key20180919073752_B2","doi-asserted-by":"publisher","first-page":"7140","DOI":"10.1016\/j.vaccine.2010.08.082","article-title":"Rabies vaccines: WHO position paper\u2013recommendations","volume":"28","author":"World Health Organization","year":"2010","journal-title":"Vaccine"},{"key":"key20180919073752_B3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12250-012-3244-y","article-title":"Analysis on factors related to rabies epidemic in China from 2007\u20132011","volume":"27","year":"2012","journal-title":"Virol Sin"},{"key":"key20180919073752_B4","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","year":"2005","journal-title":"Bull World Health Organ"},{"key":"key20180919073752_B5","first-page":"309","article-title":"Rabies vaccines: WHO position paper","volume":"85","author":"WHO","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"key20180919073752_B6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ijid.2005.10.007","article-title":"Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey","volume":"11","year":"2007","journal-title":"Int J Infect Dis"},{"key":"key20180919073752_B7","unstructured":"Chinese Center for Disease Control and Prevention. 2013. The national statistical for the incidence and mortality of notifiable infectious disease. Accessed 18 November 2013. (In Chinese.) http:\/\/chinacdc.cn\/AnalysisService\/showFlashKY.jsp?id=010213941550107970001636100000&name=2012\u5e74\u5168\u56fd\u6cd5\u5b9a\u4f20\u67d3\u75c5\u62a5\u544a\u53d1\u75c5\u3001\u6b7b\u4ea1\u7edf\u8ba1\u8868.doc."},{"key":"key20180919073752_B8","unstructured":"National Health and Family Planning Commission of the People's Republic of China. 2013. Chinese Yearbook of Health Statistics 2012. Accessed 18 November 2013. (In Chinese.) http:\/\/www.nhfpc.gov.cn\/htmlfiles\/zwgkzt\/ptjnj\/year2012\/index2012.html."},{"key":"key20180919073752_B9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/1471-2334-9-210","article-title":"Epidemiological investigations of human rabies in China","volume":"9","year":"2009","journal-title":"BMC Infect Dis"},{"key":"key20180919073752_B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/vbz.2008.0046","article-title":"Rabies in China: an update","volume":"9","year":"2009","journal-title":"Vector Borne Zoonotic Dis"},{"key":"key20180919073752_B11","first-page":"521","article-title":"Study on the status of infection and distribution of rabies virus in China","volume":"31","year":"2010","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"key20180919073752_B12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1863-2378.2011.01416.x","article-title":"Risk factors for human rabies in China","volume":"59","year":"2012","journal-title":"Zoonoses Public Health"},{"key":"key20180919073752_B13","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.3201\/eid1112.040775","article-title":"Human rabies in China","volume":"11","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"key20180919073752_B14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/0264-410X(94)90004-3","article-title":"Do anaesthetics and surgical stress increase the risk of post-exposure rabies treatment failure?","volume":"12","year":"1994","journal-title":"Vaccine"},{"key":"key20180919073752_B15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0264-410X(88)90225-3","article-title":"Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1 schedule application for postexposure treatment","volume":"6","year":"1988","journal-title":"Vaccine"},{"key":"key20180919073752_B16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0264-410X(86)90138-6","article-title":"An evaluation of second generation tissue culture rabies vaccines for use in man: a four-vaccine comparative immunogenicity study using a pre-exposure vaccination schedule and an abbreviated 2-1-1 postexposure schedule","volume":"4","year":"1986","journal-title":"Vaccine"},{"key":"key20180919073752_B17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1590\/S0036-46651995000400012","article-title":"Studies on human anti-rabies immunization in Brazil. II. Preliminary evaluation of the 2-1-1 schedule for human pre-exposure anti-rabies immunization, employing suckling mouse brain vaccine","volume":"37","year":"1995","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"key20180919073752_B18","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3969\/J.ISSN.1007-6611.2011.09.012","article-title":"Study on efficacy and safety of rabies vaccine by three different immunization programs","volume":"42","year":"2011","journal-title":"J Shanxi Med Univ"},{"key":"key20180919073752_B19","first-page":"2","article-title":"The comparative observation of wild dog vaccine immune program and five needle 2-1-1 four needles of immunization programs","volume":"5","year":"2011","journal-title":"Chin J Mod Drug Appl"},{"key":"key20180919073752_B20","doi-asserted-by":"publisher","first-page":"220","DOI":"10.4161\/hv.7.2.14003","article-title":"The immunogenicity and safety of vaccination with purified Vero cell rabies vaccine (PVRV) in China under a 2-1-1 regimen","volume":"7","year":"2011","journal-title":"Hum Vaccin"},{"key":"key20180919073752_B21","first-page":"667","article-title":"Observation on the safety and immunogenicity of antirabic vaccine among different immune procedures","volume":"28","year":"2012","journal-title":"J Med Pest Control"},{"key":"key20180919073752_B22","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.4161\/hv.28420","article-title":"Comparison of safety and immunogenicity of purified chick embryo cell vaccine using Zagreb and Essen regimens in patients with category II exposure in China","volume":"10","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"key20180919073752_B23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0264-410X(91)90244-Z","article-title":"One-year study of the 2-1-1 intramuscular postexposure rabies vaccine regimen in 100 severely exposed Thai patients using rabies immune globulin and Vero cell rabies vaccine","volume":"9","year":"1991","journal-title":"Vaccine"},{"key":"key20180919073752_B24","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0264-410X(97)00207-7","article-title":"Persistence of humoral immunity to rabies 1100 days after immunization and effect of a single booster dose of rabies vaccine","volume":"15","year":"1997","journal-title":"Vaccine"},{"key":"key20180919073752_B25","first-page":"491","article-title":"Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 Clinical Investigator Group","volume":"76","year":"1998","journal-title":"J Bull World Health Organ"},{"key":"key20180919073752_B26","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/S0264-410X(98)00427-7","article-title":"Rabipur: a reliable vaccine for rabies protection","volume":"17","year":"1999","journal-title":"Vaccine"},{"key":"key20180919073752_B27","first-page":"400","article-title":"The comparative observation of adverse reactions between \u201c2-1-1\u201d and traditional \u201c5-doses\u201d regimen","volume":"26","year":"2013","journal-title":"Chin J Biol"},{"key":"key20180919073752_B28","first-page":"1154","article-title":"Analysis on adverse reaction rate of rabies vaccine and its influencing factors","volume":"26","year":"2013","journal-title":"Chin J Biol"},{"key":"key20180919073752_B29","first-page":"190","article-title":"Observation of the side effects induced by rabies vaccine of \u201c2-1-1\u201d procedure","volume":"5","year":"2013","journal-title":"Med Infect"},{"key":"key20180919073752_B30","first-page":"456","article-title":"Comparative study on the safety of rabies vaccine for human use under four immune procedures between ChengDa and Rabipur","volume":"6","year":"2012","journal-title":"J Dis Monit Control"},{"key":"key20180919073752_B31","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1016\/j.vaccine.2004.12.008","article-title":"The real cost of rabies post-exposure treatments","volume":"23","year":"2005","journal-title":"Vaccine"},{"key":"key20180919073752_B32","first-page":"254","article-title":"Study on the compliance and economic cost of rabies vaccination","volume":"16","year":"2010","journal-title":"Chin J Vaccine Immun"},{"key":"key20180919073752_B33","first-page":"44","article-title":"Economic burden and compliance analysis of human rabies vaccine in Meizhou","volume":"38","year":"2012","journal-title":"South China J Prev Med"},{"key":"key20180919073752_B34","first-page":"1076","article-title":"Analysis of compliance for rabies vaccination","volume":"11","year":"2011","journal-title":"J Trop Med"},{"key":"key20180919073752_B35","first-page":"471","article-title":"Discussion on the \u201c2-1-1\u201d procedure for rabies vaccine","volume":"28","year":"2012","journal-title":"Chin J Public Health Manag"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1128\/CVI.00531-14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:51:13Z","timestamp":1627591873000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00531-14"}},"subtitle":[],"editor":[{"given":"C. J.","family":"Papasian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,11,12]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,30]]},"published-print":{"date-parts":[[2015,1]]}},"alternative-id":["10.1128\/CVI.00531-14"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00531-14","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,12]]}}}